Clinical Trial Update: Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fludarabine versus chlorambucil as first-line therapy in older patients with previously untreated chronic lymphocytic leukemia (CLL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Fludarabine (Fludarabine)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED